Physician profile
Alex Bauer
NPI 1255826434
$13,291.07
in general payments reported to CMS, 2019-2025
17 companies · $1,041 in 2025
The $1,041 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.26 · 2020: $115 · 2021: $19.55 · 2022: $177 · 2023: $6,088 · 2024: $5,828 · 2025: $1,041.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,038 · Travel and Lodging: $3,949 · Food and Beverage: $2,461 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,037.88 |
| Travel and Lodging | $3,948.94 |
| Food and Beverage | $2,461.05 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,317.73 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $369.54 | 2022-2025 | Phasix Mesh, Arista Ah Flexitip, Arista |
| Solventum Corporation | $171.76 | 2024-2025 | Prevena, V.A.C. Veraflo |
| Bard Peripheral Vascular, INC. | $75.46 | 2020 | |
| Aimmune Therapeutics, INC. | $49.97 | 2025 | Zenpep |
| Atricure, INC. | $44.32 | 2022-2023 | |
| Medtronic Vascular, INC. | $39.35 | 2020 | |
| Abbvie INC. | $31.80 | 2025 | |
| Smith+Nephew, INC. | $27.00 | 2025 | Stravix Pl |
| Baxter Healthcare | $25.58 | 2025 | Perclot |
| Janssen Biotech, INC. | $23.71 | 2025 | Tremfya |
| Mallinckrodt Enterprises LLC | $23.26 | 2019 | |
| Heron Therapeutics, INC. | $21.97 | 2024 | Zynrelef |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.55 | 2021 | |
| Genentech USA, INC. | $17.02 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocon Biologics INC | $16.86 | 2025 | Hulio |
| Innovation Technologies INC | $16.19 | 2024 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.